<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04905485</url>
  </required_header>
  <id_info>
    <org_study_id>V136 (VIOME-001 v5.0)</org_study_id>
    <nct_id>NCT04905485</nct_id>
  </id_info>
  <brief_title>Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes</brief_title>
  <official_title>Developing a Model to Better Predict Diabetes and/or Risk of Developing Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Viome</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Viome</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants who were previously Viome costumers who signed informed consent to participate&#xD;
      and self reported type 2 diabetes or pre-diabetes were enrolled. They provided stool samples&#xD;
      to VIOME and were provided with precision diet and supplement recommendations. The&#xD;
      information obtained from this study is used to train a model to predict diabetes and/or&#xD;
      risks of developing diabetes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 21, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Participants all received diet and supplement recommendations based on their microbiome results.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in VIOME's Type 2 diabetes risk score</measure>
    <time_frame>~3 months</time_frame>
    <description>&quot;Type 2 diabetes risk score&quot; is computed using Viome's molecular data from stool and HBA1C level self reported. The risk score is 1-100. 1 Indicates a low chance of developing T2D and 100 indicates a high chance of developing T2D.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2912</enrollment>
  <condition>Diabetes Type 2</condition>
  <condition>Diabetes</condition>
  <condition>Pre-diabetes</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All participants received the intervention in this trial. They received recommendations on their diets and supplements based on their results of microbiome expression.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>VIOME Precision Nutrition Program</intervention_name>
    <description>Precision diet and supplement recommendations based on participants' microbiome results.</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>VPNP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Viome customer&#xD;
&#xD;
          -  GI test collected at home using Viome test kit&#xD;
&#xD;
          -  US citizen&#xD;
&#xD;
          -  18+ years old&#xD;
&#xD;
          -  Is not participating in any other Viome study&#xD;
&#xD;
          -  Must have answered the following on-boarding question with the indicated answer:&#xD;
&#xD;
        &quot;Do you or did you ever have diabetes or prediabetes?&quot;&#xD;
&#xD;
          -  Signed and dated informed consent prior to any trial-specific procedures are performed&#xD;
&#xD;
          -  Able to speak and read English&#xD;
&#xD;
          -  Willing and able to follow the trial instructions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable/unwilling to complete the informed consent form and the questionnaires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guruduth Banavar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Viome</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Viome Research Institute</name>
      <address>
        <city>Bothell</city>
        <state>Washington</state>
        <zip>98011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 24, 2021</study_first_submitted>
  <study_first_submitted_qc>May 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Viome</keyword>
  <keyword>Diabetes Type 2</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Pre-diabetes</keyword>
  <keyword>VPNP</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Supplements</keyword>
  <keyword>Precision</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

